Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease-An update overview

JP Assolini, ACM Carloto, BT da Silva Bortoleti… - European Journal of …, 2022 - Elsevier
Leishmaniasis is a neglected tropical disease that has a wide spectrum of clinical
manifestations, ranging from visceral to cutaneous, with millions of new cases and …

Current applications of plant-based drug delivery Nano Systems for Leishmaniasis Treatment

DB Dos Santos, JA Lemos, SEM Miranda, LD Di Filippo… - Pharmaceutics, 2022 - mdpi.com
Leishmania is a trypanosomatid that causes leishmaniasis. It is transmitted to vertebrate
hosts during the blood meal of phlebotomine sandflies. The clinical manifestations of the …

Protoscolicidal activity of Atriplex halimus leaves extract against Echinococcus granulosus protoscoleces

S Bouaziz, M Amri, N Taibi, R Zeghir-Bouteldja… - Experimental …, 2021 - Elsevier
Cystic echinococcosis, an endemic zoonosis in Algeria, is caused by the development of the
helminth Echinococcus granulosus. Surgery remains the main treatment despite inducing …

[HTML][HTML] Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?

MBC Brioschi, EM Coser, AC Coelho… - International Journal of …, 2022 - Elsevier
A growing number of studies have demonstrated the in vitro potential of an impressive
number of antileishmanial candidates in the past years. However, the lack of uniformity …

Trypanocidal potential of synthetic p-aminochalcones: In silico and in vitro evaluation

NDB Gomes, EP Magalhães, LR Ribeiro… - Bioorganic …, 2023 - Elsevier
Chagas disease (CD) is a neglected tropical disease of worldwide health concern, caused
by the flagellate protozoan Trypanosoma cruzi (T. cruzi), endemic in Latin America and …

Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compounds

JL Hernández-Rivera, JC Espinoza-Hicks… - Molecular Diversity, 2023 - Springer
Drug therapy for leishmaniasis remains a major challenge as currently available drugs have
limited efficacy, induce serious side-effects and are not accessible to everyone. Thus, the …

4-Nitrochalcone as a potential drug in non-clinical breast cancer studies

CM Galindo, L Milani, LTF de Lima, ER Adami… - Chemico-Biological …, 2024 - Elsevier
Breast cancer is a high-magnitude public health problem, continually challenging physicians
and scientists worldwide in the field of drug therapy. 4-nitrochalcone (4NC) is a phenolic …

Synthesis, Vibrational Analysis, Thermal analysis, Quantum-chemical Calculation, Molecular Docking and Dynamics, DMPK and Evaluation of the Antichagasic …

JVS Nunes, EM Marinho, CHA Roberto… - Journal of Molecular …, 2024 - Elsevier
Chagas disease affects 7 million people worldwide and is endemic in 20 Latin American
countries. It is estimated to cause about 14,000 deaths annually and more than 75 million …

Proteomic identification of metabolic changes in Paracoccidioides brasiliensis induced by a nitroheteroarylchalcone

MABC Júnior, LC Silva, OB Rocha, AA Oliveira… - Future …, 2023 - Taylor & Francis
Aim: To access the metabolic changes caused by a chalcone derivative (LabMol-75)
through a proteomic approach. Methods: Proteomic analysis was performed after 9 h of …

Synthesis of aminochalcones and in silico evaluation of their antiparasitic potential against Leishmania

LL Bezerra, FWQ Almeida-Neto… - Journal of …, 2023 - Taylor & Francis
Leishmaniasis disease is a serious public health problem. This disease reaches about 10 to
12 million people, and 20–30 thousand people die yearly. The disease treatment is realized …